Effect of 2-(4-benzyl-piperidino)-1-(4-hydroxyphenyl)-1-propranolol on adenylate cyclase and 3,5'-cyclic AMP phosphodiesterase in vitro.
D015105:3',5'-Cyclic-AMP Phosphodiesterases / Q000037:antagonists & inhibitors*; D000067956:Adenylyl Cyclase Inhibitors; D000818:Animals; D003994:Bucladesine / Q000494:pharmacology; D066298:In Vitro Techniques; D008099:Liver / Q000201:enzymology; D008297:Male; D010208:Papaverine / Q000494:pharmacology; D010726:Phosphodiesterase Inhibitors; D010880:Piperidines / Q000494:pharmacology*; D051381:Rats; D013806:Theophylline / Q000494:pharmacology
D000067956:Adenylyl Cyclase Inhibitors; D010726:Phosphodiesterase Inhibitors; D010880:Piperidines; D003994:Bucladesine; D013806:Theophylline; D010208:Papaverine; D015105:3',5'-Cyclic-AMP Phosphodiesterases